Assignee
SYNAPTOGENIX INC
US·2 granted patents·10 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
12 records- 0183US2024025870A1Pkc-activating compounds for the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2023·Application pending·0 cites
- 0280US11820745B2PKC-activating compounds for the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2022·Granted Nov 21, 2023·0 cites·6 claims
- 0377US12016837B2Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2022·Granted Jun 25, 2024·0 cites·3 claims
- 0474US2024390324A1Methods of treating and preventing neurodegenerative diseases with hgf activating compoundsSYNAPTOGENIX INC·Filed 2024·Application pending·0 cites
- 0574US2025064776A1Treatment of amyotrophic lateral sclerosis using pkc activatorsSYNAPTOGENIX INC·Filed 2024·Application pending·0 cites
- 0666US2021308099A1Methods and compositions for treatment of alzheimer's disease and other neurodegenerative disordersSYNAPTOGENIX INC·Filed 2021·Application pending·0 cites
- 0765US2024408056A1Methods for repairing nerve damage using pkc activating therapeutic agentsSYNAPTOGENIX INC·Filed 2024·Application pending·0 cites
- 0862US2022184028A1Treatment of amyotrophic lateral sclerosis using pkc activatorsSYNAPTOGENIX INC·Filed 2021·Application pending·0 cites
- 0958US2022133687A1Methods of treating and preventing neurodegenerative diseases with hgf activating compoundsSYNAPTOGENIX INC·Filed 2020·Application pending·0 cites
- 1057US2024180869A1Treatment of multiple sclerosis using pkc activatorsSYNAPTOGENIX INC·Filed 2022·Application pending·0 cites
- 1157US2024165075A1Treatment of optic nerve inflammation using pkc activatorsSYNAPTOGENIX INC·Filed 2022·Application pending·0 cites
- 1253US2023000943A1Method of inducing synaptogenesis by administering angiotensin and analogues thereofSYNAPTOGENIX INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →